 BUENA, N.J., Jan. 22, 2021 GLOBE NEWSWIRE -- Teligent, Inc. NASDAQ: TLGT Teligent or the Company, a New Jersey-based specialty generic pharmaceutical company, previously received notice from The Nasdaq Stock Market Nasdaq stating that the Company was not in compliance with Nasdaq Listing Rule 5250c1 as a result of the Company not having timely filed its Quarterly Report on Form 10-Q for the three months ended September 30, 2020 the Form 10-Q with the Securities and Exchange Commission. Upon filing of the Form 10-Q on December 31, 2020, the Company regained compliance with Nasdaq Listing Rule 5250c1 and this matter is now closed. 